In 2019, the FDA approved the first medication designed to treat postpartum depression. The medication is called brexanolone and is delivered intravenously by a medical professional over the course of a few days. However, typical antidepressants, which are more accessible, can also treat postpartum depression. The disorder is often best treated through a combination of medication and therapy.